1Rioufol G, Gilard M, Finet G, et al. Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound. Circulation, 2004, 110:2875 -2880.
2DeGraba TJ. Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation.Stroke, 2004, 35:2712 -2719.
3Geisler T, Bhatt DL. The role of inflammation in atherothrombosis: current and future strategies of medical treatment. Med Sci Monit, 2004,10:RA308 -RA316.
4Tedgui A. The role of inflammation in atherothrombosis: implications for clinical practice. Vasc Med, 2005, 10:45 -53.
5Chew DP, Bhatt DL, Robbins MA, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol, 2001,88:672 -674.
6Hermann A, Rauch BH, Braun M, et al. Platelet CD40 ligand(CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets, 2001, 12:74 -82.
7Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost, 2005, 31: 381 - 392.
8Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.Circulation, 2005, 111: 2233 - 2240.
